Cialis (Eli Lilly and Company)
Welcome to the PulseAid listing for the Cialis drug offered from Eli Lilly and Company. This Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Eli Lilly and Company |
NON-PROPRIETARY NAME: | Tadalafil |
SUBSTANCE NAME: | TADALAFIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2003-11-26 |
END MARKETING DATE: | 0000-00-00 |
Cialis HUMAN PRESCRIPTION DRUG Details:
Item Description | Cialis from Eli Lilly and Company |
LABELER NAME: | Eli Lilly and Company |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2003-11-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0002-4462_a300bb97-176e-4771-8b31-3246d3f773f8 |
PRODUCT NDC: | 0002-4462 |
APPLICATION NUMBER: | NDA021368 |
Other TADALAFIL Pharmaceutical Manufacturers / Labelers: